Copyright © 2011-2018 Ascletis Inc. All rights reserved.


News & Events

Investor Center




About  Us

About Us

Research & Development

Research & Development Pipeline Partership Investor Center News & Events Careers
Contact    Home    Home-Ch


Ascletis focuses on building a global specialty therapeutics business dedicated to discovering and developing important new treatments for cancer and infectious diseases.

We leverage U.S./European innovation and pharmaceutical/biotech strategic experience and China’s capital efficiency with a goal of establishing in the near term a sustainable business and accelerated revenues through the in-licensing, late-stage clinical development, and commercialization of new medicines for the growing Chinese pharmaceutical marketplace. At the same time, we will build long-term value through the discovery, demonstration of clinical proof-of-concept, and global partnering of novel therapeutics for life-threatening diseases.

Three operation sites:

Hangzhou has been named the Best City for Investment in China by World Bank and ranked #1 in Best Business Place in China by Forbes. HHTZ has been ranked #3 among the 53 national high-tech zones in terms of per capita profit. Learn More >>

RTP was globally ranked #4 in the 2010 International Ranking of Emerging Biotech Hubs by Business Facilities for its combination of excellent, low-cost infrastructure and highly networked scientific working groups. Learn More >>

Shaoxing has been named the Top Ten Commercial Cities in China by Forbes and the one of six Golden Cities on Investment Enviorment in China by World Bank. Shaoxing’s GDP ranks top 30 cities in China in past decade. Learn More >>

Research Triangle Park

Corporate Overview

Management Team

Board of Directors


Founders Board of Directors Management Team